Researchers have discovered hundreds of drug targets to treat disease—and find more every day. But until recently, 90% of these targets have been considered “undruggable,” and therefore untreatable. Using our revolutionary high-throughput platform, we can now discover drugs at a volume, speed, and efficiency thousands of times greater than has ever been possible.
We are designing life-changing medicines at genomic scale.
Covalent molecules serve as a universal key to unlocking undruggable targets for both non-covalent and covalent drug development. Many of the most effective therapeutics in history, including penicillin, AZT, and many lifechanging oncology drugs were developed through this approach.
The Totus Platform discovers drugs with unprecedented volume, speed, and efficiency, allowing us to create a comprehensive catalog of drugs across the entire human genome.
We are developing drugs against poorly treated, advanced forms of cancer, starting with a breakthrough medicine for the most mutated oncogene. We have also built out a robust pipeline of oncology programs.
We have the power to treat cancer, heart disease, neurodegeneration, and beyond—within this decade.
In the News
Totus Medicines CEO to Present at Next-Generation Undruggable Conference
PR Newswire 10 11 2022
East Coast biotech company relocates HQ to Emeryville
San Francisco Business Times 03 31 2022
Totus Medicines Announces New San Francisco Bay Area Headquarters & Expanded Lab Space
PR Newswire 03 31 2022